Skip to Main Content

Paper Details

Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia.
0
2023
C-reactive protein, Fatty liver, NAFLD, Nonalcoholic Fatty Liver Disease, Nonalcoholic fatty liver disease, People, T2DM, Type 2 Diabetes, cholesterol, glucose, haemoglobin, hepatic steatosis, high-density lipoprotein- cholesterol, patients, people, triglyceride, type 2 diabetes
Author NameAffiliation
Jaakko TuomilehtoKing Abdulaziz University
Jaakko TuomilehtoUniversity of Helsinki
Jaakko TuomilehtoFinnish Institute for Health and Welfare
  • 1 - 3

Datasets

Release 1.2